Viracta Therapeutics Overview

Viracta Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for VIRX.

Quarterly EBIT

-$10.19M

↑ 19.19% YoY

As of Sep 30, 2024

Annual EBIT (TTM)

-$47.21M

↑ 3.67% YoY

Trailing 12 months ending Sep 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin